Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study

被引:28
作者
Kinoshita, Takayuki [1 ]
Nakayama, Takahiro [2 ]
Fukuma, Eisuke [3 ]
Inokuchi, Masafumi [4 ]
Ishiguro, Hiroshi [5 ]
Ogo, Etsuyo [6 ]
Kikuchi, Mari [7 ]
Jinno, Hiromitsu [8 ]
Yamazaki, Naoya [9 ]
Toi, Masakazu [10 ]
机构
[1] Natl Canc Ctr, Dept Breast Surg, Tokyo, Japan
[2] Osaka Int Canc Inst, Dept Breast & Endocrine Surgety, Osaka, Japan
[3] Kameda Med Ctr, Breast Ctr, Dept Breast Surg, Kamogawa, Japan
[4] Kanazawa Med Univ Hosp, Dept Breast & Endocrine Surg, Kanazawa, Ishikawa, Japan
[5] Int Univ Hlth & Welf Hosp, Dept Med Oncol, Nasushiobara, Japan
[6] Kurume Univ, Sch Med, Dept Radiol, Kurume, Fukuoka, Japan
[7] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Diagnost Imaging, Tokyo, Japan
[8] Teikyo Univ, Dept Surg, Sch Med, Tokyo, Japan
[9] Natl Canc Ctr, Dept Dermatol Oncol, Tokyo, Japan
[10] Kyoto Univ, Dept Breast Surg, Kyoto, Japan
来源
FRONTIERS IN ONCOLOGY | 2019年 / 9卷
关键词
scalp cooling; chemotherapy-induced alopecia; breast cancer; hair loss; hair volume recovery; anthracycline; docetaxel; side effects; INDUCED HAIR LOSS; DOCETAXEL; DEVICE; WOMEN;
D O I
10.3389/fonc.2019.00733
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study aimed to assess the efficacy of scalp-cooling devices in preventing chemotherapy-induced alopecia in Japanese breast cancer patients and investigate whether a scalp-cooling device improves hair volume recovery over a 12 weeks period after completing chemotherapy. Methods: This multicenter controlled trial included women with breast cancer undergoing chemotherapy in Japan between February 2016 and March 2018. The primary endpoint was the proportion of patients with no alopecia at the end of chemotherapy. The secondary endpoint included hair volume at 12 weeks after completing chemotherapy. Results: A total of 48 patients were enrolled; of them, 34 and 14 were sequentially allocated to the scalp-cooling group using the Paxman Hair Loss Prevention System and the control group, respectively. There was no significant difference in average age between the scalp-cooling and the control groups (50.0 +/- 9.6 vs. 49.0 +/- 9.0 years). More than 50% of patients in each group had stage II breast cancer (scalp-cooling group: 53.1%; control group: 64.3%), more than 90% received adjuvant chemotherapy (scalp-cooling group: 96.9%; control group: 92.9%), and more than 60% were treated with a docetaxel/cyclophosphamide regimen (scalp-cooling group: 75.0%; control group: 64.3%). There were more patients judged to have no alopecia at the end of chemotherapy in the scalp-cooling group than in the control group (26.7% [8/30] vs. 0% [0/13]; P = 0.011). The proportion of patients with alopecia who experienced an increase in hair volume of >50% within 12 weeks duration after chemotherapy was 85.7% (24/28) in the scalp-cooling group and 50.0% (6/12) in the control group. No patient developed serious adverse events related to the scalp-cooling device. Conclusions: The use of a scalp-cooling device prevented alopecia with acceptable safety for Japanese patients. In addition, scalp cooling resulted in faster recovery of hair volume after chemotherapy, even in patients for whom scalp cooling failed to prevent chemotherapy-induced alopecia.
引用
收藏
页数:9
相关论文
共 50 条
[31]   A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients [J].
Suyoun Chung ;
Siew-Kee Low ;
Hitoshi Zembutsu ;
Atsushi Takahashi ;
Michiaki Kubo ;
Mitsunori Sasa ;
Yusuke Nakamura .
Breast Cancer Research, 15
[32]   Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study [J].
Kang, Danbee ;
Kim, Im-Ryung ;
Choi, Eun-Kyung ;
Im, Young Hyuck ;
Park, Yeon Hee ;
Ahn, Jin Seok ;
Lee, Jeong Eon ;
Nam, Seok Jin ;
Lee, Hae Kwang ;
Park, Ji-Hye ;
Lee, Dong-Youn ;
Lacouture, Mario E. ;
Guallar, Eliseo ;
Cho, Juhee .
ONCOLOGIST, 2019, 24 (03) :414-420
[33]   Improving Information Provision on Chemotherapy-Induced Alopecia and Scalp Cooling: A Comprehensive Approach Including A Website and Web-Based Decision Tool [J].
van den Hurk, Corina ;
Keizer-Heldens, Paulien ;
Raats, Ilse ;
Hoeijmakers, Kim ;
Mols, Floortje .
ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2019, 6 (04) :336-342
[34]   The Efficacy of Paxman Scalp Cooling System in Preventing Hair Loss in Breast Cancer Patients Receiving Chemotherapy in Western India - Multi-centre Retrospective Cohort Study [J].
Mekha, Mangesh ;
Joshi, Ashish ;
Maniar, Vashishth ;
Maheshwari, Udip ;
Joshi, Kshitij ;
Kalaskar, Pritam ;
Sheth, Smit ;
Kendre, Pradip ;
Morzaria, Disha ;
Korgavkar, Reshma ;
Pethe, Chandrashekhar ;
Dhande, Sonal .
INDIAN JOURNAL OF DERMATOLOGY, 2024, 69 (01) :16-23
[35]   Minimal added value of wetting hair before scalp cooling to prevent chemotherapy-induced alopecia in cancer patients - results from the Dutch Scalp Cooling Registry [J].
Heibloem, Robin E. ;
Komen, Manon M. C. ;
Ilozumba, Onaedo U. C. ;
van den Hurk, Corina J. G. .
SUPPORTIVE CARE IN CANCER, 2023, 31 (05)
[36]   Scalp Cooling to Prevent Chemotherapy-Induced Alopecia The Time Has Come [J].
Hershman, Dawn L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (06) :587-588
[37]   Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients [J].
Ohsumi, Shozo ;
Kiyoto, Sachiko ;
Takahashi, Mina ;
Takashima, Seiki ;
Aogi, Kenjiro ;
Shimizu, Sachie ;
Doi, Miyuki .
SUPPORTIVE CARE IN CANCER, 2021, 29 (10) :6119-6125
[38]   Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer [J].
Rugo, Hope S. ;
Klein, Paula ;
Melin, Susan Anitra ;
Hurvitz, Sara A. ;
Melisko, Michelle E. ;
Moore, Anne ;
Park, Glen ;
Mitchel, Jules ;
Bageman, Erika ;
D'Agostino, Ralph B., Jr. ;
Ver Hoeve, Elizabeth S. ;
Esserman, Laura ;
Cigler, Tessa .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (06) :606-614
[39]   Patient and nursing staff perspectives on automated scalp cooling (ASC) for chemotherapy-induced alopecia in breast cancer [J].
Ueberroth, Benjamin E. ;
Kosiorek, Heidi E. ;
Nafissi, Nellie N. ;
Ertz-Archambault, Natalie ;
Howland, Allison ;
Haddad, Tufia ;
Northfelt, Donald W. .
SUPPORTIVE CARE IN CANCER, 2024, 32 (07)
[40]   Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy [J].
Vasconcelos, Ines ;
Wiesske, Alexandra ;
Schoenegg, Winfried .
BREAST, 2018, 40 :1-3